glp 1 analogues contraindications for agonists Using information from the NPF Medical Board's publication in JAMA Dermatology, Benefits and Risks of GLP-1

With the recent announcement that the shortage of Ozempic and Wegovy is officially over, the FDA has declared that compounding pharmacies must stop producing and selling compounded semaglutide by May 22, 2025

Whether you're on a GLP-1 medication and want complementary support, or you're taking the natural route entirely, this patch was made for you

Understanding the mechanism, risk factors, and practical management strategies can help you stay comfortable while pursuing your health goals

As 2025 gets underway, we take a look at what lies ahead for the highly dynamic market for effective anti-obesity medications (AOMs)

Janumet is the brand name for a combination...

Worried about Ozempic and blood clots